
Novavax COVID-19 vaccine, flu shot coadministration likely ‘viable strategy,’ company says
Fox News
Maryland-based biotech company Novavax on Monday announced its experimental COVID-19 vaccine remained effective when coadministered with an approved flu shot.
Preliminary findings from a Phase 3 clinical trial, posted ahead of peer review, involved 431 volunteers in the U.K. enrolled in a coadministration sub-study, in which all participants received an approved flu shot. About half also received the company’s investigational COVID-19 vaccine while the rest were given placebo.More Related News

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












